You are here: All Products  > GenFleet Partners Three Pre-Clinical RAS Candidates with Verastem in $625.5 Million Deal

GenFleet Partners Three Pre-Clinical RAS Candidates with Verastem in $625.5 Million Deal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.